"Fumarates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on fumaric acid.
| Descriptor ID |
D005650
|
| MeSH Number(s) |
D02.241.081.337.302
|
| Concept/Terms |
Fumaric Acid Esters- Fumaric Acid Esters
- Acid Esters, Fumaric
- Esters, Fumaric Acid
- Fumarate Esters
- Esters, Fumarate
|
Below are MeSH descriptors whose meaning is more general than "Fumarates".
Below are MeSH descriptors whose meaning is more specific than "Fumarates".
This graph shows the total number of publications written about "Fumarates" by people in this website by year, and whether "Fumarates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fumarates" by people in Profiles.
-
Schafer JJ, Zimmerman M, Walshe C, Cerankowski J, Shimada A, Keith SW. Weight changes in patients with sustained viral suppression switching tenofovir disoproxil fumarate to tenofovir alafenamide. Obesity (Silver Spring). 2022 06; 30(6):1197-1204.
-
Orkin C, Squires KE, Molina JM, Sax PE, Sussmann O, Lin G, Kumar S, Hanna GJ, Hwang C, Martin E, Teppler H. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial. Clin Infect Dis. 2021 07 01; 73(1):33-42.
-
Guo L, Shestov AA, Worth AJ, Nath K, Nelson DS, Leeper DB, Glickson JD, Blair IA. Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine. J Biol Chem. 2016 Jan 01; 291(1):42-57.
-
Maser RE, Lenhard MJ, Kolm P, Edwards DG. Direct renin inhibition improves parasympathetic function in diabetes. Diabetes Obes Metab. 2013 Jan; 15(1):28-34.
-
Bergset J, Storozynsky E, Bisognano JD. Renin inhibition for hypertension: selecting the right role for a new class of drug. Am J Ther. 2010 Mar-Apr; 17(2):182-7.
-
Sanoski CA. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension. Pharmacotherapy. 2009 Feb; 29(2):193-212.
-
Garg M, Chawla S, Prasad KN, Roy R, Sikora SS, Kumar R, Husain M, Khetrapal CL, Gupta RK. Differentiation of hydatid cyst from cysticercus cyst by proton MR spectroscopy. NMR Biomed. 2002 Aug; 15(5):320-6.
-
Okun MR, Patel RP, Donnellan B, Lever WF, Edelstein LM, Epstein D. DOPA compared with dihydroxyfumarate as co-factor in peroxidase-mediated oxidation of tyrosine to melanin. Histochemical studies with neutrophils, eosinophils, mast cells, melanoma cells and neurons. Histochemie. 1971; 27(4):331-4.